- Danaher Corp.’s (NYSE:DHR) shares soared 8.5% after the company agreed to acquire biopharma business of General Electric Co. (NYSE:GE) for $21.4 billion in cash
- Shares of Spark Therapeutics Inc. (NASDAQ:ONCE) jumped 120.1% after the company entered into a definite agreement merger agreement with Roche Holding (SIX:ROG) AG for $4.8 billion in cash
- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) shares surged 74.7% after France's Ipsen agreed to acquire Canada-based group house in a deal valued at up to $1.31 billion
- Shares of Carter’s Inc. (NYSE:CRI) climbed 8.4% after posting fourth quarter 2018 adjusted earnings per share of $2.84, surpassing the Zacks Consensus Estimate of $2.57
General Electric Company (GE): Free Stock Analysis Report
Danaher Corporation (DHR): Free Stock Analysis Report
Spark Therapeutics, Inc. (ONCE): Free Stock Analysis Report
Carter's, Inc. (CRI): Free Stock Analysis Report
Clementia Pharmaceuticals Inc. (CMTA): Free Stock Analysis Report
Original post
Zacks Investment Research